| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5acc73c34cf2b348b8bce69d72b9c37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d607d32ce3da33038adbbb3a2ab61da9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 |
| filingDate |
2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e148c3bc0b49f8271684e4d7bf815af9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a672f98ccd28eddbdaedb9d1fd9bd19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b82acab6faaa6bb84a70510d99f7486b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dd5ecfa93715ad3e4a33c5e35c71870
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2c41d7c4771cd2d307cbcce733fe9b3 |
| publicationDate |
2022-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022007878-A1 |
| titleOfInvention |
USE OF β-1 ADRENOCEPTOR ANTAGONIST FOR PREPARING COMPOSITION FOR REDUCING EPITHELIAL CELL DAMAGE INDUCED BY EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR AND INHIBITING CANCER CELLS |
| abstract |
A use of a β-1 adrenoceptor antagonist for preparing a composition for reducing or preventing normal epithelial cell damage induced by an epidermal growth factor receptor inhibitor and inhibiting cancer cells. The composition comprising the β-1 adrenoceptor antagonist can be administered to reduce the normal epithelial cell damage induced by the epidermal growth factor receptor inhibitor, and can be administered together with the epidermal growth factor receptor inhibitor for inhibiting cancer cells in a synergistic manner. |
| priorityDate |
2020-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |